Results 121 to 130 of about 1,352 (137)

CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma. [PDF]

J Nucl Med
Makala H, Sheehan-Klenk J, Lee W, Chung JY, Baidoo KE, Nambiar D, Choyke PL, Escorcia FE.   +7 more
europepmc   +1 more source

Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix-Targeted Radiopharmaceutical against Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Hachey JS, Viray TD, Carrasco SE, Carter LM, Esposito TVF, Matasci M, Ravazza D, Neri D, Lewis JS.   +8 more
europepmc   +1 more source

Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates. [PDF]

Clin Cancer Res
Bidkar AP, Bidlingmaier S, Wadhwa A, Mayne E, Raveendran A, Naik S, Xue C, Basak M, Bobba KN, Patiño-Escobar B, Greenland N, Camara Serrano JA, Steri V, Chou J, Wiita A, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Liu B, Flavell RR.   +21 more
europepmc   +1 more source

Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management. [PDF]

Front Oncol
Almutairi WM, Zheng QH, Langer M, Oderinde OM.   +3 more
europepmc   +1 more source

Nectin-4-Targeted Radiotheranostics for Personalized Cancer Therapy: A Systematic Review. [PDF]

J Nucl Med
Schäfer L, Altunay B, Morgenroth A, Vogg A, Derks Y, Lammers T, Peña Q, Mottaghy FM, Lütje S.   +8 more
europepmc   +1 more source

Through every lens: assessing the impact of chemical modifications on antibody-conjugates using in vivo imaging. [PDF]

Npj Imaging
Edupuganti VVSR, Escorcia FE, Schnermann MJ.   +2 more
europepmc   +1 more source

Prospective pilot study with [⁸⁹Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). [PDF]

Eur J Nucl Med Mol Imaging
Rousseau C, Heyman MF, Ferrer L, Rauscher A, Morel A, Rusu D, Frenel JS, Taupin M, Vilcot L, Allam N, Robert M, Campone M, Campion L, Kraeber-Bodéré F.   +13 more
europepmc   +1 more source

Enhanced Tumor-to-Background Contrast with [⁵²Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer. [PDF]

Pharmaceuticals (Basel)
Csikos C, Ngô MT, Vágner A, Nagy G, Ország G, Nagy T, Váradi B, Sajtos GZ, Kapus I, Szoboszlai Z, Szikra D, Tircsó G, Krasznai ZT, Molnár S, Garai I, Trencsényi G.   +15 more
europepmc   +1 more source

Synthesis and preclinical development of a novel ⁶⁸Ga/⁸⁹Zr-Labelled ανβ6-integrin targeting trimer. [PDF]

EJNMMI Radiopharm Chem
Gariglio G, A Patiño Álvarez F, A Zierke M, Stangl S, Rheinfrank T, Holzleitner N, Kossatz S, Decristoforo C.   +7 more
europepmc   +1 more source

A zirconium-89-labeled antibody-drug conjugate PET probe for noninvasive monitoring of Nectin4 expression in breast cancer and lung cancer. [PDF]

Cell Rep Phys Sci
Huang W, Wang T, Liang Y, Chao F, Yang Q, Barnhart TE, Engle JW, Li L, Kang L, Cai W.   +9 more
europepmc   +1 more source